CATALYST DOSSIER · UPDATED 2026-11-04
$TRV
insurance · convergence -9 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $TRV?
Quantitative
Revenue (CY2026Q2) : $12.15B (+31.0% YoY)
Net Income (CY2026Q2) : $2.21B (+46.3% YoY)
Net Margin (CY2026Q3) : 15.4%
Catalysts
Multi-spoke convergence : 5 convergent signals fired: orphan_lean, auto_macro_adp_payrolls, auto_macro_durable_goods, auto_macro_fx_rates, auto_macro_options_gex
Risks
Macro headwind : Sector macro lean -1 — broader-tape pressure
Bear case
Macro sector overhang : Sector insurance carrying -1 macro lean from convergence engine
Sympathy basket (cerebro)
ALL via insurance r=+0.00 intra-sector (score 7)
MET via insurance r=+0.00 intra-sector (score 6)
PGR via insurance r=+0.00 intra-sector (score 1)
AIG via insurance r=+0.00 intra-sector (score 0)
CINF via insurance r=+0.00 intra-sector (score 0)
PRU via insurance r=+0.00 intra-sector (score -2)
Signals Firing
orphan_lean auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates auto_macro_options_gex
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-20 sec_top_gappers +1.0% +0.8% — 2026-10-20 sec_top_moat_emerging +1.0% +0.8% — 2026-10-19 sec_top_gappers +2.9% +2.7% ✓ hit 2026-10-19 sec_top_moat_emerging +2.9% +2.7% ✓ hit 2026-10-16 sec_top_gappers +0.1% -1.1% — 2026-10-16 sec_top_moat_emerging +0.1% -1.1% —
Lifetime: 2/6 wins · hit-rate 33.3% on +2% intraday
Sympathy Basket ALL via insurance · score 7 MET via insurance · score 6 PGR via insurance · score 1 AIG via insurance · score 0 CINF via insurance · score 0 PRU via insurance · score -2
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.